New hope: starting addiction meds at needle exchanges shows promise
NCT ID NCT03150173
Summary
This study tested whether starting buprenorphine, a medication for opioid addiction, directly at syringe exchange programs helps people get into treatment faster and stay in it longer. Researchers compared this approach to simply referring people to a health clinic. The goal was to see if easier access to treatment could help control addiction and reduce risky behaviors linked to HIV.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIATE ADDICTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BOOM!Health Harm Reduction Center
The Bronx, New York, 10451, United States
-
New York Harm Reduction Educators
New York, New York, 10035, United States
-
Washington Heights CORNER Project
New York, New York, 10033, United States
Conditions
Explore the condition pages connected to this study.